Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,723.00
(
0.35%
)
US TECH 100
24,112.40
(
0.40%
)
Dow Jones
47,068.89
(
0.26%
)
Brent Oil
99.40
(
1.11%
)
Bitcoin
74,349.58
(
-0.66%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 143354

Wednesday, 06/06/2012 11:13:52 AM

Wednesday, June 06, 2012 11:13:52 AM

Post# of 257251
Those Actemra monotherapy results look very impressive to me.

had a DAS28 remission rate of 40 percent with ACTEMRA versus 11 percent with adalimumab (DAS28 <2.6)



Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now